AssetMark Inc’s AngioDynamics ANGO Stock Holding History

AssetMark Inc’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208	Hold	16	–	–	﹤0.01%	3421
2026 Q1	$182	Hold	16	–	–	﹤0.01%	3332
2025 Q4	$205	Hold	16	–	–	﹤0.01%	3251
2025 Q3	$179	Hold	16	–	–	﹤0.01%	3080
2025 Q2	$159	Sell	16 -33	-67%	-$323	﹤0.01%	2905
2025 Q1	$460	Sell	49 -49	-50%	-$515	﹤0.01%	2430
2024 Q4	$898	Buy	98 +74	+308%	+$544	﹤0.01%	2261
2024 Q3	$187	Buy	+24	New	+$173	﹤0.01%	2170
2018 Q1	–	Sell	-12	Closed	–	–	1426
2017 Q4	$0	Sell	12 -254	-95%	-$4.33K	﹤0.01%	1862
2017 Q3	$5K	Buy	266 +78	+41%	+$1.31K	﹤0.01%	1137
2017 Q2	$3K	Buy	188 +126	+203%	+$1.99K	﹤0.01%	1165
2017 Q1	$1K	Buy	+62	New	+$1.04K	﹤0.01%	1184

Other funds holding ANGO

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

AssetMark Inc's ANGO Position: Q2 2026 in Review

AssetMark Inc held its AngioDynamics (ANGO) position steady in Q2 2026 at 16 shares worth $208. The position accounts for ﹤0.01% of the portfolio, ranked #3421.

AssetMark Inc first reported a position in ANGO in Q1 2017 and has held it in 12 quarters since. The position peaked at $5K in Q3 2017. 42 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

AssetMark Inc held 16 shares of AngioDynamics worth $208 as of Q2 2026.
AssetMark Inc left its AngioDynamics share count unchanged in Q2 2026.
AngioDynamics made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3421 holding.
AssetMark Inc first reported a position in AngioDynamics in Q1 2017 and has held it in 12 quarters since.
AssetMark Inc's AngioDynamics position peaked at $5K in Q3 2017.
42 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.